It is important to note that in patients with higher T-stages, as well as higher PSA-values, the impact of 68Ga-PSMA-PET is larger on restating than in other tumor stages, meaning that in those patients a larger amount of up-stagings were observed than for lower tumor stages. The gene discussed is FOLH1; the disease is neoplasm.